|
|
|
| home > white papers > Clinical Trials in Russia Orange Paper: 1st Quarter 2014 - Synergy Research Group |
|
|
 WHITE PAPERS |
|
Synergy Research Group
|
|
Clinical Trials in Russia Orange Paper: 1st Quarter 2014
|
|
In summary, Russia remains a very popular geography for local, regional,
and global pharmaceutical companies to conduct clinical trials.
Sponsors mention the following reasons for conducting studies in Russia:
1. Fast patient enrollment due to the centralized medical infrastructure.
2. Nearly 100% patient retention
3. GCP trained and certified Investigative Sites generating high quality data
4.
Low cost: Average per patient cost is 60% to 70% below US and European
prices due to the low cost of Investigators and the high concentration
of patients in therapeutically aligned medical centers
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
RWS Life Sciences Welcomes New VP of Quality
RWS Life Sciences welcomes Clarice Streets, ASQ, CMQ, OE, as Vice
President, Global Quality and Process, in charge of the strategic
direction and implementation of its Quality system, underlying
organizational processes, and change management.
More info >> |
|
 |
White Papers |
 |
|
7 Common Myths about QP Training Debunked: A Guide for Senior Managers
RSSL
The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >> |
|
 |
Industry Events |
 |
6th Annual Single Cell Analysis Congress
8-9 November 2018, London, UK
Oxford
Global is proud to present its 6th Annual Single Cell Analysis Congress taking
place on 8-9 November 2018 in London. Part of the Genomics
& Synthetic Biology Series UK, the congress will bring together over 600
end users representing internationally renowned research & academic
institutions, clinical research institutions, healthcare organisations as well
as leading pharmaceutical and biotech companies.
More info >> |
|
|
|
